temozolomide has been researched along with alpha-hydroxyglutarate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, M; Kato, K; Kato, Y; Motomura, A; Motomura, K; Natsume, A; Ohka, F; Ranjit, M; Saito, K; Senga, T; Soga, T; Wakabayashi, T | 1 |
| Alghamri, MS; Appelman, H; Carney, SV; Castro, MG; Edwards, MB; Garcia-Fabiani, MB; Gauss, JC; Haase, S; Kadiyala, P; Kleer, CG; Li, D; Liu, Y; Lowenstein, PR; Moon, JJ; Núñez, FJ; Nunez, FM; Schwendeman, A; Sun, Y; Taher, A; Yu, M; Zhao, L | 1 |
2 other study(ies) available for temozolomide and alpha-hydroxyglutarate
| Article | Year |
|---|---|
Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation.
Topics: Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Glioma; Glutaminase; Glutamine; Glutarates; HEK293 Cells; Humans; Isocitrate Dehydrogenase; Ketoglutaric Acids; Metabolome; Mutation; Temozolomide | 2014 |
Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice.
Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cellular Reprogramming; Chemoradiotherapy; Gain of Function Mutation; Glioma; Glutarates; Humans; Immunologic Memory; Isocitrate Dehydrogenase; Mice; Temozolomide; Tumor Suppressor Protein p53; X-linked Nuclear Protein | 2021 |